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ARTICLE
Strategies for penicillin V dendronization with cationic
carbosilane dendrons and study of antibacterial properties
Elena Fuentes-Paniagua, José M. Hernández-Ros, Juan Soliveri, José L. Copa-Patiño, Rafael Gómez,
Javier Sánchez-Nieves, and F. Javier de la Mata
Abstract: Strategies to synthesize a cationic carbosilane dendron containing the antibiotic penicillin V potassium salt (PenVK)
at the focal point are discussed. The preparation of such a compound requires the use of systems with no donor atoms such as
N or S in their framework, because their presence favours the rupture of the penicillin -lactam ring. The antibacterial activity
of the new dendron containing ammonium groups, at the periphery, and the PenV moiety, at the focal point, against gram-
positive Staphylococcus aureus strains was evaluated. These results were compared with those obtained for free PenVK, a related
cationic dendron without a penicillin moiety at the focal point, and also compared with an equimolar mixture of this last
dendron with free PenV. The data obtained indicate that, on one hand, the conjugation or interaction of PenV with cationic
dendrons reduces its activity in comparison with free PenVK. On the other hand, the penicillin dendron is able to release the
antibiotic in the presence of esterease, due to the breaking of the ester bond in this derivative.
Key words: dendritic molecules, carbosilane dendrons, antibacterial, penicillin, antibiotic.
Résumé : Il est question dans le présent article de stratégies pour synthétiser un dendron de carbosilane cationique contenant
en son point focal le sel potassique de la pénicilline V (PenVK), un antibiotique. La préparation d’un tel composé requiert l’emploi
de systèmes dont la structure est dépourvue de donneurs d’atomes, tels que l’azote (N) ou le soufre (S), car ceux-ci causent la
rupture du cycle -lactame de la pénicilline. L’activité antimicrobienne de ce nouveau dendron dotés de groupes ammonium en
périphérie et du groupement PenV au point focal a été évaluée en présence de souches de Staphylococcus aureus à gram positif.
Nous avons comparé ces résultats à ceux qui ont été obtenus pour la PenVK libre, pour un dendron cationique apparenté sans
groupement pénicilline au point focal, ainsi que pour un mélange équimolaire de ce dernier dendron avec la PenV libre. Les
données obtenues indiquent que l’activité de la PenV conjuguée aux dendrons cationiques ou en présence de ceux-ci est réduite
par rapport à celle de la PenVK libre. Par ailleurs, nous avons montré qu’en présence d’estérase, le dérivé pénicilline-dendron est
capable de libérer l’antibiotique par clivage de sa liaison ester. [Traduit par la Rédaction]
Mots-clés : molécules dendritiques, dendrons de carbosilane, antibactérien, pénicilline, antibiotique.
Introduction
The widespread use and misuse of antibiotics have favored the
appearance of antibiotic-resistant bacteria,1–3 creating a major
public health concern.4 The problem is worsened by the ability of
bacteria to create biofilms,5 which are involved in the majority of
infection diseases caused by bacteria.6 Thereby, the need of find-
ing compounds with non-specific antibacterial activity to fight
resistance and (or) reduce antibiotic dependence is a priority.7,8
The bacterial cell walls are formed with negative lipoproteins
and divalent cations such as Mg2+ and Ca2+ acting as glue.9 Thus,
quaternary ammonium salts (QAS) have become popular antimi-
crobials due to their ability to replace these cations and destroy
the cell wall.9–11 Another advantage of some QAS is their solubility
in water, which allows them to kill bacteria in water solution.12
The incorporation of QAS to polymers generates polycations that
present a high surface charge. The multivalency of these polyam-
monium macromolecules such as polymers,13 hyperbranched
polymers,14 and dendrimers15,16 increases the activity with re-
spect to monofunctional molecules.7,13,17
Dendrimers and dendrons are multibranched macromolecules
designed step by step, which leads to well-defined structures.18–20
Dendrimers are spherical molecules, whereas dendrons are cone-
shaped molecules, presenting an extra active moiety, the focal
point, that can be used to attach a second functionality or to
dendronize materials. The well-known structures of these systems
make it easier to establish structure–activity relationships. Several
types of ammonium dendrimers, depending on their dendritic struc-
ture, have shown antibacterial properties.21–25 Their activity is in-
creased by the presence of hydrophobic chains, which enables their
penetration into the phospholipid bilayer, leading to the disintegra-
tion of the bacterial membrane.11,26 Regarding dendrons, antimicro-
bial studies are scarce,27 and usually, they are associated to the
generation of dendronized materials,28–30 because the focal point is
an excellent anchorage position for functionalization.
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Dendrimers have also been employed as drug carriers by elec-
trostatic interaction between drugs and surface groups, conjuga-
tion of drug to dendrimer, or by encapsulation of drug inside a
hyperbranched framework.31,32 For example, it has been reported
that some dendrimers enhance solubility and activity of anti-
biotics.33–37 Moreover, a synergistic effect has been observed for
some combinations of dendrimers with antibacterial properties
and antibiotics.38–40
One type of dendrimers is based on carbosilane framework,
which contains very low polar C–C and Si–C bonds.41,42 The deco-
ration of the surface of dendrimers with ammonium functions
introduces antimicrobial properties and water solubility to these
dendrimers.43–46 Recently, we published an evaluation of antibac-
terial activity of cationic carbosilane dendrimers and dendrons by
comparing generation, core of dendrimers, focal point of den-
drons, and type of ammonium groups.47 These results highlight
the good activity obtained for low-generation systems (generation
one for dendrimers and generation two for dendrons with six and
four ammonium groups, respectively) against both gram-positive
and gram-negative bacteria and also against resistant S. aureus
strains. Moreover, these systems did not generate resistance after
continuous treatments. We also reported the synergy produced
after the combination of a cationic dendrimer with an amoebicide
compound (chlorhexidine digluconate).48
Taking into account these results, we have considered the eval-
uation of cationic carbosilane dendrons of second generation as
antibiotic carriers, as it could be expected that combination of
biocide compounds with different modes of action could act syn-
ergistically.49 As an antibiotic, we have chosen a penicillin deriv-
ative (penicillin V, PenV) for its simplicity and the presence of one
carboxylate moiety. This anionic group will be used to interact
electrostatically with the cationic dendrons50 or to allow conjuga-
tion to the dendron employing an adequate group at the focal
point.51 The synthetic procedure to obtain the new dendrons and
also the difficulties found to do it, their characterization, and
antibacterial activity against S. aureus are discussed.
Experimental
General considerations
All reactions were carried out under inert atmosphere, and sol-
vents were purified from appropriate drying agents when neces-
sary. NMR spectra were recorded on a Varian Unity VXR-300
(300.13 (1H), 75.47 (13C) MHz) or on a Bruker AV400 (400.13 (1H),
100.60 (13C), 40.56 (15N), 79.49 (29Si) MHz). Chemical shifts () are
given in ppm. 1H and 13C resonances were measured relative to
internal deuterated solvent peaks considering TMS = 0 ppm;
meanwhile, 29Si resonances were measured relative to external
TMS employing 1H–29Si HMBC experiments. When necessary, as-
signment of resonances was done from HSQC, HMBC, COSY,
TOCSY, and NOESY NMR experiments. Thiol-ene reactions were
carried out employing a HPK 125 W mercury lamp from Heraeus
Noblelight with maximum energy at 365 nm, in normal glassware
under an inert atmosphere. Elemental analyses were performed on a
LECO CHNS-932. Mass spectra were obtained from an Agilent 6210.
Compounds HS(CH2)2NMe2·HCl 2,2=-dimethoxy-2-phenylacetophenone
(DMPA), MeI, HSiMe2Cl, HSiMeCl2, LiAlH4, NaHCO3, penicillin V potas-
sium salt (PenVK), platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane
complex solution (Karstedt’s catalyst), and porcine liver esterease
wereobtainedfromcommercial sources.CompoundsNH2Gn(NMe2)m,52
[NH2Gn(S-NMe3)m]m+1,47 ClG1V2,53 and ClG1A254 were synthesized as pub-
lished.
Synthesis of selected compounds
The syntheses of all compounds are described in the Supple-
mentary data, with only a selection mentioned herein.
ClG1(Si-NMe2)2 (11)
An excess of allyl-dimethylamine (0.21 mL, 1.76 mmol) and two
drops of Karsted’s catalyst were added to a solution of ClG1(SiH)2
(6) (0.145 g, 0.44 mmol) in THF (2 mL). The reaction mixture was
heated at 80 °C in a sealed ampoule under inert atmosphere for
one night and then evaporated to dryness to remove the solvent
and residual allyl-dimethylamine. Afterwards, hexane (10 mL) was
added, and the solution was filtered through active carbon and
dried under vacuum to yield 11 as a pale yellow oil (0.194 g, 88%).
1H NMR (CDCl3):  −0.06 (s, 12 H, SiMe2), 0.04 (s, 3 H, SiMe), 0.44 (t,
Ja = 8.4 Hz, 4 H, SiCH2CH2CH2N), 0.57 (m, 10 H, SiCH2CH2CH2Si and
ClCH2CH2CH2Si), 1.29 (m, 4 H, SiCH2CH2CH2Si), 1.42 (m, 4 H,
SiCH2CH2CH2N), 1.72 (m, 2 H, ClCH2CH2), 2.19 (m, 16 H, CH2NMe2),
3.47 (t, Jb = 6.9 Hz, 2 H, ClCH2). 13C{1H} NMR (CDCl3):  −5.2 (SiMe),
−3.4 (SiMe2), 11.6 (ClCH2CH2CH2Si), 12.8 (SiCH2CH2CH2N), 18.3, 18.5
and 20.0 (SiCH2CH2CH2Si), 22.1 (SiCH2CH2CH2NMe2), 27.7 (ClCH2CH2),
45.5 (–NMe2), 48.1 (ClCH2), 63.4 (CH2NMe2). MS: [M + H]+ = 493.4 uma
(calcd = 493.4 uma). Anal. Calcd for C24H57ClN2Si3 (493.43 g/mol): C,
58.42; H, 11.64; N, 5.68; Exp.: C, 58.89; H, 11.57; N, 5.81.
ClG1(Si-NMe3I)2 (13)
A mixture of 11 (0.220 g, 0.44 mmol) and MeI (0.11 mL, 1.76 mmol)
in THF (50 mL) were stirred for 16 h. Afterward, volatiles were re-
moved under vacuum, and the remaining solid was washed with
Et2O (50 mL), obtaining 13 as a white solid (0.300 g, 87%).
1H NMR (DMSO-d6):  −0.07 (s, 3 H, SiMe), 0.00 (s, 12 H, SiMe2), 0.38
and 0.56 (m, 14 H, SiCH2), 1.31 (m, 4 H, SiCH2CH2CH2Si), 1.62 (m,
6 H, CH2CH2N+ and ClCH2CH2), 3.05 (s, 18 H, –NMe3+), 3.25 (t, Ja =
7.8 Hz, 4 H, CH2N+), 2.58 (t, Jb = 6.5 Hz, ClCH2). 13C{1H} NMR (DMSO-
d6):  −5.6 (SiMe), −3.9 (SiMe2), 10.6 (SiCH2CH2CH2N+), 16.4–17.4
(SiCH2CH2CH2Si), 18.6 (CH2CH2N+), 26.7 (ClCH2CH2), 47.8 (ClCH2),
51.6 (–NMe3+), 67.4 (SiCH2CH2CH2NMe3+).29 Si-NMR (DMSO-d6):
 2.1 (SiMe), 2.4 (SiMe2). ESI: (776.21 g/mol) q = 1 (649.31 [M–I]+). Anal.
Calcd for C26H63ClI2N2Si3 (777.31 g/mol): C, 40.17; H, 8.17; N, 3.60;
Exp.: C, 40.78; H, 8.39; N, 3.93.
(PenV)G1(Si-NMe3I)2 (15)
To a solution of 14 (0.050 g, 0.06 mmol) in dry DMF, PenVK
(0.027 g, 0.07 mmol) was added in the presence of ether crown
18C6 (0.002 g, 0.01 mmol) and a catalytic amount of NaI. The
mixture was heated at 80 °C in a sealed ampoule under argon
atmosphere for 40 h, after which volatiles were removed. After
washing the residues with water, this dendron was obtained as a
very hygroscopic white solid (0.062 g, 89%).
1H NMR (CDCl3):  0.00 (s, 12 H, SiMe2), 0.04 (s, 3 H, SiMe), 0.57 (m,
14 H, SiCH2), 1.29 (m, 4 H, SiCH2CH2CH2Si), 1.48 (s, 3 H, CMe2), 1.58
(s, 3 H, CMe2), 1.70 (m, 6 H, CH2CH2N+ and OCH2CH2), 3.41 (s, 18 H,
–NMe3+), 3.63 (m, 4 H, CH2N+), 4.08 (t, Ja = 8.4 Hz, 2 H, (CO)OCH2),
4.43 (s, 1 H, CH(CMe2)), 4.53 (s, 2 H, OCH2CO), 5.56 (d, Jb = 4.3 Hz,
1 H, CHS), 5.70 (m, 1 H, NHCH), 6.90 (d, Jc = 7.6 Hz, 2 H, CHAr), 7.01
(t, Jd = 7.4 Hz, 1 H, CHAr), 7.30 (m, 2 H, CHAr). 13C{1H} NMR (CDCl3):
 −5.0 (SiCH3), −3.2 (SiMe2), 9.9 (CH2Si), 11.4 (SiCH2CH2CH2N+), 17.9,
18.0, and 18.3 (SiCH2CH2CH2Si), 19.8 (CH2CH2N+), 23.2 (OCH2CH2),
26.8 and 32.0 (SCMe2), 53.7 (–NMe3+), 58.0 (NHCH), 64.7 (SCMe2),
67.1 (CH2N+), 67.7 (OCH2CO), 68.4 (COOCH2), 69.5 (CHS), 70.5 (CH-
COO), 114.7 (CHAr), 122.4 (CHAr), 129.8 (CHAr), 156.8 (COAr), 167.6,
167.8, and 173.0 (C=O). ESI: (1090.32 g/mol) q = 1 (963.42 [M–I]+), q =
2 (418.26 [M–2I]2+). Anal. Calcd for C42H80I2N4O5SSi3 (1091.24 g/mol):
C, 46.23; H, 7.39; N, 5.13; Exp.: C, 45.94; H, 7.07; N, 4.43.
DOSY NMR measurements
DOSY experiments were carried out on a Bruker Advance 400 at
25 °C. The values of midpoint between gradients () and gradient
length () were adjusted for free PenVK and for compound 14 in
their solutions, and these values were later used in two different
experiments for the mixture PenVK–14, not observing significant
differences in the final result (Supplementary Fig. S6).
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Staphylococcus aureus (CECT 240, gram-positive bacteria) were ob-
tained from the Spanish Type Culture Collection (CECT).
MIC and MBC
The minimal inhibitory concentration (MIC) of the products
was measured in 96-well tray microplates by microdilution tray
preparations following the international standard methods ISO
20776-1.55 Assays were run in duplicate microplates and three
different wells for each concentration analyzed in the microplate.
Solutions of the products were prepared in the range of 0.25–
1024 ppm adding in each well 100 L of one of these solutions,
100 L of double concentration Mueller Hinton (Scharlau, ref. 02–
136), and 5 L of a bacteria suspension of 2 × 107 CFU/mL. Micro-
plates were incubated at 37 °C for 19 h using an ultra microplate
reader ELx808iu (Bio-Tek Instruments), considering the MIC the
minimal concentration for which no turbidity was observed. The
minimal bactericidal concentration (MBC) was calculated by inoc-
ulating Petri dishes containing Mueller-Hinton agar with 3 L of
the samples used for MIC assessment. Samples were tested as
droplets on the plates. Microbial growth on plates was monitored
after 24 h of incubation at 37 °C. The MBC was determined as the
minimal concentration at which no growth was detected.
Results and discussion
Synthesis and characterization of dendrons
To clarify the discussion of the compounds studied herein, the
following nomenclature for dendrons has been used: [XGn(Y-Z)m],
where X refers to the focal point, Gn means carbosilane skeleton
and generation (Fig. 1), Y indicates functionalization of the periphery
by hydrosilylation (Y = Si) or hydrothiolation (Y = S), and Z and m
correspond to the peripheral functional groups and their num-
bers on the surface, respectively.
Because the antibacterial results previously obtained by our
group for carbosilane dendrons showed the best activity for
second-generation derivatives containing a sulfur atom close to
the surface of the dendron,47 we have focused our efforts on ob-
taining a second-generation dendron with a PenV fragment at the
focal point. Nonetheless, the reactions with the first-generation
dendrons were carried out to find the adequate procedure and
properly characterize the compounds.
Initially, we attempted to anchor the penicillin moiety by amide
bond involving the carboxylic group of PenV and a primary amine
at the focal point of the cationic dendron NH2G1(S-NMe3)2]2+47 or the
related neutral derivative NH2G1(S-NMe2)252 (Scheme 1). However,
the reaction of neutral PenV with these dendrons failed due to
instability of the -lactam ring toward the amino function, ob-
serving in the 1H NMR spectra the disappearance of the original
resonances belonging to this ring (data not shown). This instabil-
ity of the -lactam ring in the presence of –NH2 functions has been
exploited for the preparation of benzylpenicilloyl–dendrimer
conjugates to evaluate penicillin allergy.56
Alternatively, we proceeded to incorporate the PenV moiety to
a vinyl dendron by direct reaction of the PenVK with the dendron
containing a Br–C bond at the focal point, BrG1V2, in a similar way
to other modifications introduced in these dendrons (Supplemen-
tary Scheme S1).52 Thus, after reaction treatment and purification,
the corresponding dendron (PenV)G1V2 (1) was obtained as a yel-
lowish oil in good yield. The main NMR data that confirmed this
transformation were the resonances corresponding to the CH2
moiety of the new ester bond, observed at  4.16 1H NMR spectrum
and at  65.4 13C NMR spectrum, respectively.
Unfortunately, subsequent modification of the periphery of 1
via thiol-ene addition failed, leading again to the rupture of the
-lactam ring, probably caused by a nucleophilic attack of the
thiol function to the carbonyl carbon of this ring (Scheme 1).57
Nevertheless, the halogen–PenV exchange seemed to be a prom-
ising procedure to obtain dendrons with a PenV unit at the focal
point. Hence, we designed a cationic dendron with a Cl–C bond at
the focal point and cationic peripheral functions at the periphery.
The reason for the presence of a Cl–C bond instead of a Br–C bond
is the clearly enhanced reactivity of the latter towards amines.
For the synthesis of this new dendron (Supplementary Scheme S2),
we started from ClG1V253 and carried out a thiol-ene addition with
cysteamine hydrochloride (HS(CH2)2NMe2·HCl) under UV irradia-
tion, obtaining [ClG1(S-NMe2H)2]2+ (2) as a white solid. The forma-
tion of this compound was confirmed by NMR spectroscopy: the
resonances of the vinyl groups disappeared in both 1H NMR and
13C NMR spectra; the new chain formed Si(CH2)2S presented in the
1H NMR two multiplets at  0.87 (SiCH2) and at 2.60 (CH2S) and in
the 13C NMR two signals at  13.5 (SiCH2) and at 26.0 (CH2S); and
the resonances of the new chain introduced S(CH2)2NMe2H were
also observed. Next, basic treatment of 2 led to the neutral den-
dron ClG1(S-NMe2) (3) that was obtained as a yellowish oil. The 1H
NMR spectrum showed a clear shifting of the NMe2 groups from 
2.73 in 2 to  2.24 in 3. Finally, addition of MeI to 3 afforded the
cationic dendron [ClG1(S-NMe3)2]2+ (4), which was isolated as a pale
yellow solid. In this case, the resonances of the Me3N+ groups were
shifted to higher frequency, being observed in the 1H NMR spec-
trum at  3.07.
Again, the reaction of dendron [ClG1(S-NMe3)2]2+ (4) with PenVK
(Scheme 1) did not render the desired dendron, once again observ-
ing the rupture of the -lactam ring by means of modification
Fig. 1. Drawing of cationic dendrons of second generation [XG2(Si-NMe3)4]4+ (X = Cl, (14); X = PenV (16)).
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of their resonances in the 1H NMR spectrum. In this case, this
-lactam ring probably suffered a nucleophilic attack of the
thioether function. It is important to note that this reaction re-
quires heating over 80 °C.
To bypass all these drawbacks in the synthesis of a cationic
carbosilane dendron containing a PenV moiety, we moved to mod-
ification of the dendron surface by hydrosilylation processes in-
stead of thiol-ene addition, with the aim to avoid the presence of
any donor atom in the final dendron. This methodology success-
fully allowed us to prepare cationic dendrons with PenV at the
focal point.
Thus, starting from ClG1A254 and using typical reactions for the
preparation of carbosilane dendritic systems (hydrosilylation, alk-
enylation, and Cl–H substitution; Scheme 2),58 we obtained den-
drons with a Cl–C bond at the focal point and Si–H peripheral
groups ClGn(SiH)m (n = 1, m = 2 (6); n = 2, m = 4 (10)). Treatment
of these derivatives with allyldimethylamine in the presence of
Karstedt’s catalyst59 afforded the neutral dendrons ClGn(Si-NMe2)m
(n = 1, m = 2 (11); n = 2, m = 4 (12) (Scheme 3). NMR spectroscopy
clearly showed the incorporation of the new propylene chain
(Si(CH2)3N) to the dendrimer structure by means of the resonances
in the 1H NMR spectra at  ca. 0.44 (SiCH2), 1.40 (CH2), and 2.20
(CH2N) and in the 13C NMR spectra at  ca. 12.8 (SiCH2), 22.1 (CH2),
and 63.4 (CH2N). These compounds were easily transformed into
the cationic ones [ClGn(Si-NMe3)m]m+ (n = 1, m = 2 (13); n = 2, m = 4
(14) by addition of MeI (Scheme 3; Fig. 1). The typical shifting to
higher frequency of the methyl (MeN) resonances was observed in
the 1H NMR spectra (Supplementary Figs. S1 and S2). Subsequent
heating of 13 and 14 with PenVK yielded the goal dendrons
[(PenV)Gn(Si-NMe3)m]m+ (n = 1, m = 2 (15); n = 2, m = 4 (16) (Scheme 3;
Fig. 1), which were isolated in good yields as highly hygroscopic
pale yellow solids. The solubility was generation dependent, being
G1 dendron soluble in chlorinated solvents, alcohols, and DMSO
but not in water, whereas G2 dendron was soluble in water and
other highly polar solvents but not in chlorinated solvents. NMR
(Figs. 2 and 3), MS (Supplementary Fig. S3), and elemental analysis
were in accordance with this formulation. The main NMR data
confirming formation of these dendrons were the resonances as-
sociated to the ester fragment. The CH2O group was observed at
about  4.1 and  67 in the 1H and 13C spectra, respectively, and the
corresponding carbon atom of the carbonyl group at about  173
in the 13C spectra. Furthermore, the binding of PenV to the den-
dron was confirmed by DOSY NMR, showing the joint diffusion of
both moieties (Supplementary Fig. S3), in comparison with the
mixture of PenV and dendron 14 (Supplementary Fig. S6). The
formation and stability of the dendrons containing the PenV moi-
Scheme 1. Failed attempts to obtained penicillin (PenV) functionalized dendrons containing sulfur atoms.
Scheme 2. Synthesis of carbosilane dendrons containing peripheral Si–H bonds and a Cl–C bond at the focal point ClGn(SiH)m (n = 1, m = 2 (6);
n = 2, m = 4 (10)). (i) HSiMe2Cl, 60 °C, [Pt], 4 h; (ii) LiAlH4, Et2O, 0 °C to room temperature, 16 h; (iii) HSiMeCl2, 60 °C, [Pt], 4 h; (iv) BrMg(allyl),
Et2O, 0 °C to room temperature, 16 h.
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ety 14 and 16 following this route confirms that the presence of
donor atoms such as S or N in the dendron structure was respon-
sible of -lactam ring degradation.
Antibacterial activity
For the study of the biocidal capacity of dendrons, S. aureus was
chosen as a model of gram-positive bacteria, as penicillin is a
specific antibiotic for this type of bacteria. Figure 1 depicts draw-
ings of cationic dendrons employed for the assays. To ascertain
the effect of the PenV moiety in dendron [(PenV)G2(Si-NMe3)4]4+
(16), a comparative study of the antibacterial activity of this
dendron with its parent compound [ClG2(Si-NMe3)4]4+ (14) and
an equimolecular mixture of PenVK salt plus dendron 14 was
carried out. Table 1 summarizes the MIC and MBC of these
dendrons.
The data obtained point out the following facts: (i) there were
slight differences in the antibacterial response of dendrons with
or without PenV at the focal point [ClG2(Si-NMe3)4]4+ (14) and
[(PenV)G2(Si-NMe3)4]4+ (16); (ii) there was much lower activity of
the PenV fragment in 16 than that of the free PenV; and (iii) a MIC
for the stoichiometric mixture of PenVK and 14 was similar to that
obtained for free PenVK, whereas the MBC increased to 0.78 ppm
(with respect to PenV), which was much higher than that of free
PenVK.
The decrease of the bactericide activity (MBC) of the mixture
PenVK–14 compared with free PenVK could be explained in terms
of availability of the antibiotic, because PenV is an anionic com-
pound capable of interacting with the cationic dendron50 and,
thus, likely to diminish its availability. Comparison of the diffu-
sion coefficients of free PenVK and PenVK in an equimolecular
Scheme 3. Synthesis of dendrons [(PenV)Gn(Si-NMe3)m]m+ (n = 1, m = 2 (15); n = 2, m = 4 (16)) with PenV at the focal point and cationic
peripheral groups derived by hydrosilylation. (i) (allyl)NMe2, 60 °C, [Pt]; (ii) MeI, THF, room temperature, 16 h; (iii) PenVK, ether crown 18C6,
NaI, DMF, 80 °C, 40 h.
Fig. 2. 1H NMR of [(PenV)G2(Si-NMe3)4]4+ (16) in DMSO-D6.
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mixture with dendron [ClG2(Si-NMe3)4]4+ (14) by DOSY 2D NMR
experiments showed that this coefficient is clearly smaller when
the dendron is present. This means that diffusion of PenVK is
affected by the dendron, supporting the assessment of interaction
between both systems (Supplementary Fig. S6). Although in our
case the dendron–PenV interaction seems to difficult the action of
the antibiotic, it has been reported that electrostatic interaction
between -lactam antibiotics and a polymer containing cationic
cobaltocenium units exhibit synergistic effects against methicillin
resistant S. aureus by efficiently inhibiting activity of -lactamase and
effectively lysing bacterial cells.60
In the case of dendron [(PenV)G2(Si-NMe3)4]4+ (16) with a cova-
lently bonded PenV, the higher inhibitory and bactericidal con-
centration values with respect to free PenVK are probably due to
the fact that the ester bond is not adequately split in solution. The
activity of PenV requires the availability of the carboxylate moi-
ety, which also favours its stability, as the formation of the ester
bond to conjugate penicillin to the dendron alters the crucial
equilibrium between stability and activity of the -lactam ring.61
Thus, the presence of this ester bond triggers the reactivity of the
ring, thereby affecting their activity.
With the aim of facilitating the release of the penicillin frag-
ment by rupture of the ester bond, we tested the antibacterial
activity of dendron [(PenV)G2(Si-NMe3)4]4+ (16) in the presence of
porcine liver esterase. For this experiment, we initially added one
unit of esterase per ester bond. From the first moment, the activ-
ity increased (MIC = 0.95 ppm and MBC = 0.95 ppm, with respect to
the concentration of PenV), confirming the splitting of the ester
bond. However, the obtained values were different from those for
free PenV in the absence of dendron. This may be due to the
electrostatic interactions of free PenV with the dendron or also to
partial degradation of penicillin previous to its release from den-
dron. Addition of excess esterase did not affect the behavior ob-
served in this experiment.
Conclusions
Carbosilane cationic dendrons with a penicillin moiety at the
focal point can be obtained, employing the carboxylate group of
penicillin (PenV) to be attached to the dendron. However, the
synthetic protocol requires avoiding the presence of donor atoms
or groups to avoid degradation of the -lactam ring, which is
responsible for the penicillin activity.
Evaluation of the activity of this dendron (16) and of a mixture
of cationic dendron (14) and free PenV revealed that both covalent
Fig. 3. 13C NMR of [(PenV)G2(Si-NMe3)4]4+ (16) in DMSO-D6.
Table 1. Antibacterial activity of PenV, dendrons
[XG2(Si-NMe3)4]4+ (X = Cl, 14; PenV, 16), and
equimolecular mixture of PenVK and 14 against
S. aureus.
MIC MBC
ppm [NR3+] ppm [NR3+]
PenVK 0.016 — 0.031 —
14 8 20 8 20
PenVK–14 0.012a 0.14 0.78a 9
16 2.91a 33 2.91a 33
16–esterease 0.95a 3.70 0.95a 3.70
Note: [NR3+] refers to the mol/L concentration of
ammonium groups.
arefers to ppm concentration of PenV.
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conjugation of PenV to the dendron or electrostatic interaction
between PenV and the cationic dendron reduced penicillin activ-
ity. These phenomena can be ascribed to the blocking of the car-
boxylate group of penicillin, which also favours the hydrolysis of
the -lactam ring. Hydrolysis of the ester bond in dendron 16 with
an esterease increases the activity, without reaching the values of
free penicillin. However, the release of penicillin in this system
could be useful to apply similar compounds in drug release of
drugs where the carboxylate unit does not play a key role in its
therapeutic action.
Supplementary data
Supplementary data, including complete experimental proce-
dures and selected NMR spectra, are available with the article
through the journal Web site at http://nrcresearchpress.com/doi/
suppl/10.1139/cjc-2017-0059.
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Bryszewska, M.; Appelhans, D.; Lisowska, K. Molecules 2015, 20, 19330. doi:
10.3390/molecules201019330.
(35) Aghayari, M.; Salouti, M.; Kazemizadeh, A. R.; Zabihian, A.; Hamidi, M.;
Shajari, N.; Moghtader, F. Sci. Iran. 2015, 22, 1330.
(36) Winnicka, K.; Wroblewska, M.; Wieczorek, P.; Sacha, P. T.; Tryniszewska, E. A.
Molecules 2013, 18, 8607. doi:10.3390/molecules18078607.
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S.1. Experimental Section 
S.1.1. General Considerations. All reactions were carried out under inert atmosphere and solvents 
were purified from appropriate drying agents when necessary. NMR spectra were recorded on a Varian 
Unity VXR-300 (300.13 (1H), 75.47 (13C) MHz) or on a Bruker AV400 (400.13 (1H), 100.60 (13C), 40.56 
(15N), 79.49 (29Si) MHz). Chemical shifts (δ) are given in ppm. 1H and 13C resonances were measured 
relative to internal deuterated solvent peaks considering TMS = 0 ppm, meanwhile 29Si resonances were 
measured relative to external TMS employing 1H-29Si HMBC experiments. When necessary, assignment of 
resonances was done from HSQC, HMBC, COSY, TOCSY and NOESY NMR experiments. Thiol-ene 
reactions were carried out employing a HPK 125 W mercury lamp from Heraeus Noblelight with 
maximum energy at 365 nm, in normal glassware under an inert atmosphere. Elemental analyses were 
performed on a LECO CHNS-932. Mass Spectra were obtained from an Agilent 6210. Compounds, 
HS(CH2)2NMe2ꞏHCl (Acros), 2,2’-dimethoxy-2-phenylacetophenone (DMPA) (Aldrich), MeI (Aldrich), 
HSiMe2Cl (ABCR), HSiMeCl2 (Aldrich), LiAlH4 (Acros), K2CO3 (Panreac), penicillin V potassium salt 
(PenVK), platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex solution (Karsted’s catalyst), 





4 were synthesized as published. 
S.1.2. Synthesis of compounds.  
PenG1V2 (1). PenVK (0.177 g, 0.46 mmol) and BrG1V2 (0.119 g, 0.46 mmol) were heated (80 ºC) in a 
sealed ampoule in DMF in presence of 18C6 (0.012 g, 0.04 mmol) and catalytic amounts of NaI overnight. 
Then, volatiles were removed and a CH2Cl2/H2O(NaCl) extraction was performed and the organic phase 
was dried over MgSO4 and SiO2. Finally, dendron 1 (0.157 g, 64 %) was obtained after removing the 
volatiles. 
1H-NMR (CDCl3):  -0.02 (s, 3 H, SiMe), 0.56 (t, Ja = 8.5 Hz, 2 H, SiCH2), 1.38 (m, 4 H, CH2CH2Si), 
1.48 (s, 3 H, CMe2), 1.58 (s, 3 H, CMe2), 1.68 (m, 2 H, OCH2CH2), 4.16 (m, 2 H, (CO)OCH2), 4.44 (s, 1 H, 
CH(CO)), 4.54 (s, 2 H, OCH2CO), 5.56 (d, Jb = 4.1 Hz, 1 H, CHS), 5.70 (m, 3 H, NHCH, SiCHCH2), 6.03 
S3 
 
(m, 4 H, SiCHCH2), 6.91 (d, Jc = 7.9 Hz, 2 H, CHAr), 7.01 (t, Jd = 7.4 Hz, 1 H, CHAr), 7.31 (m, 2 H, CHAr). 
13C{1H}-NMR (CDCl3):  -5.9 (SiMe), 12.6 (CH2Si), 20.1 (CH2CH2Si), 26.8 and 32.1 (SCMe2), 31.9 
(CH2CH2CH2Si), 58.0 (NHCH), 64.7 (SCMe2), 65.4 (COOCH2), 67.1 (OCH2CO), 67.8 (CHS), 70.5 
(CHCOO), 114.7 (CHAr), 122.4 (CHAr), 129.8 (CHAr), 133.1 (SiCHCH2), 136.6 (SiCHCH2), 156.9 (COAr), 
167.6, 167.8 and 173.0 (C=O). MALDI: [M+Na]+ = 525.19 uma (calcd. = 525.19 uma). Anal. Calcd. 
C25H34N2O5SSi (502.70 g/mol): C, 59.73; H, 6.82; N, 5.57;Exp.: C, 60.22; H, 7.48; N, 6.16. 
ClG1(S-NMe2ꞏHCl)2 (2). A mixture of ClG1V2 (0.200 g, 1.14 mmol), 2-(dimethylamino)ethanethiol 
hydrochloride (0.331 g, 2.34 mmol) and DMPA (0.054 g, 0.21 mmol) in THF/MeOH (2 mL/8 mL) were 
stirred under inert atmosphere and UV irradiated for 5 h. The amount of DMPA was added in two portions, 
one at the beginning of reaction and one after 2 h. Next, volatiles were removed under vacuum and the 
remaining solid was solved in the minimum amount of MeOH and precipitated with Et2O (twice) to afford 
2 as pale yellow solid (0.383 g, 76 %).  
1H-NMR (DMSO-d6): δ -0.06 (s, 3 H, SiMe), 0.59 (m, 2 H, SiCH2), 0.87 (t, Ja = 8.3 Hz, 4 H, 
SiCH2CH2S), 1.66 (m, 2 H, ClCH2CH2), 2.60 (t, Ja = 8.3 Hz, 4 H, SiCH2CH2S), 2.73 (s, 12 H, -NMe2ꞏHCl), 
2.85 (t, Jb = 7.4 Hz, 4 H, SCH2CH2N
+), 3.20 (t, Jb = 7.4 Hz, 4 H, SCH2CH2N
+), 3.59 (t, Jc = 6.5 Hz, 2 H, 
ClCH2). 
13C{1H}-NMR (DMSO-d6): δ -5.71 (SiMe), 10.4 (ClCH2CH2CH2), 13.5 (SiCH2CH2S), 24.2 
(SCH2CH2N
+), 26.0 (SiCH2CH2S), 26.8 (ClCH2CH2), 41.4 (-NMe2ꞏHCl), 47.9 (ClCH2), 55.3 (CH2N
+). 15N-
NMR (DMSO-d6): -339.0 (-NMe2H
+). 29Si-NMR (DMSO-d6):  2.2. ESI: q = 1 (421.17 [M-Cl]+). Anal. 
Calc. C16H39Cl3N2S2Si (458.07 g/mol): C, 41.95; H, 8.58; N, 6.12; S, 14.00; Exp.: C, 41.94; H, 8.93; N, 
5.49; S, 11.44. 
ClG1(S-NMe2)2 (3). This dendrimer was obtained mixing 2 (0.210 g, 0.41 mmol) and Na2CO3 (0.092 g, 
0.87 mmol) in CHCl3/H2O, extracting the organic fraction and removing the solvent under vacuum. This 
procedure yielded 3 as a yellowish oil (0.174 g, 98 %). 
1H-NMR (CDCl3): δ -0.06 (s, 3 H, SiMe), 0.58 (m, 2 H, ClCH2CH2CH2Si), 0.88 (t, Ja = 8.7 Hz, 4 H, 
SiCH2CH2S), 1.70 (m, 2 H, ClCH2CH2), 2.24 (s, 12 H, -NMe2), 2.47 (m, 4 H, SCH2CH2N), 2.52 (m, 4 H, 
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SiCH2CH2S), 2.59 (m, 4 H, SCH2CH2N), 3.49 (t, Jb = 6.8 Hz, 2 H, ClCH2). 
13C{1H}-NMR (CDCl3): δ -5.3 
(MeSi), 11.5 (ClCH2CH2CH2), 14.6 (SiCH2CH2S), 27.7 (SiCH2CH2S), 29.9 (SCH2CH2NMe2), 45.4 (-
NMe2), 48.1 (ClCH2), 59.3 (SCH2CH2NMe2). 
29Si-NMR (CDCl3):  2.1. MALDI: [M+H]+ = 385.19 uma. 
Anal. Calc. C16H37ClN2S2Si (385.15 g/mol): C, 49.90; H, 9.68; N, 7.27; S, 16.65; Exp.: C, 48.99; H, 10.38; 
N, 6.81; S, 16.84.  
ClG1(S-NMe3I)2 (4). A mixture of 3 (0.175 g, 0.45 mmol) and MeI (0.06 mL, 0.96 mmol) was stirred 
in THF for 16 h. Afterward, volatiles were removed under vacuum and the remainnig solid was washed 
with Et2O (2 x 50 mL) to obtain 4 as a white solid (0.268 g, 89 %).  
1H-NMR (DMSO-d6): δ -0.06 (s, 3 H, SiMe), 0.56 (m, 2 H, ClCH2CH2CH2Si), 0.85 (m, 4 H, 
SiCH2CH2S), 1.67 (m, 2 H, ClCH2CH2CH2Si), 2.56 (m, 4 H, SiCH2CH2S), 2.88 (m, 4 H, SCH2CH2N
+), 
3.07 (s, 18 H, -NMe3
+), 3.49 (m, 4 H, SCH2CH2N
+), 3.57 (m, 2 H, ClCH2). 
13C{1H}-NMR (DMSO-d6): δ -
5.7 (MeSi), 10.3 (ClCH2CH2CH2Si), 13.5 (SiCH2CH2S), 23.1 (SCH2CH2N
+), 26.3 (SiCH2CH2S), 26.8 
(ClCH2CH2), 47.9 (ClCH2), 51.6 (-NMe3
+), 63.9 (CH2N
+). 15N-NMR (DMSO-d6):  -330.1 (-NMe3+). 29Si-
NMR (DMSO-d6):  2.5. ESI: q = 2 (213.12 [M-2I]2+). Anal. Calc. C18H43ClI2N2S2Si (669.02 g/mol): C, 
32.31; H, 6.48; N, 4.19; S, 9.59; Obt.: C, 31.69; H, 5.93; N, 3.96; S, 8.96. 
ClG1(SiCl)2 (5). A teflon-valve ampoule containing a solution of ClG1A2 (1.000 g, 4.93 mmol) and 
Kardsted’s catalyst (3 % mol) in hexane (2 mL) was cooled to 0º C and HSiMe2Cl (2.15 mL, 19.77 mmol) 
was slowly added. After 30 min stirring at this temperature, the solution was warmed until 60º C and 
stirred for 4 h. Afterwards, volatiles were removed under vacuum, hexane was added (20 mL) and the 
solution was filtered through active carbon. Removal of volatiles under vacuum gave 5 as colorless oil 
(1.914 g, 99 %). This product is moisture sensitive and has to be stored under inert atmosphere. 
1H-NMR (CDCl3): δ -0.05 (s, 3 H, MeSi), 0.38 (s, 12 H, Me2SiCl), 0.52 (m, 6 H, SiCH2), 0.88 (m, 4 H, 
CH2SiCl), 1.25 (m, 6 H, CH2), 1.85 (m, 2 H, ClCH2CH2), 3.47 (t, J = 6.9 Hz, 2 H, ClCH2). 
13C{1H}-NMR 
(CDCl3): -5.2 (MeSi), 1.8 (Me2Si), 11.4 (ClCH2CH2CH2), 17.6 (CH2), 17.8 (CH2), 23.4 (CH2SiCl), 27.6 
(ClCH2CH2), 48.0 (ClCH2). 
29Si-NMR (CDCl3): 2.3 (MeSi), 31.1 (Me2SiCl). 
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ClG1(SiH)2 (6). An Et2O solution (40 mL) of 5  (0.229 g, 0.58 mmol) was slowly added to an Et2O 
solution (20 mL) of LiAlH4 (0.33 mL, 0.66 mmol) at 0 ºC and stirred overnight at room temperature. 
Afterward, the mixture was added over a saturated water solution of NH4Cl (50 mL) at 0 ºC, the organic 
phase was separated and the aqueous phase was extracted twice with Et2O. After drying the organic phase 
over MgSO4 and SiO2, the solution was filtered and the volatiles were removed under vacuum, yielding 6 
as colorless oil (0.145 g, 76 %). 
1H-NMR (CDCl3): δ -0.06 (s, 3 H, MeSi), 0.04 (d, J = 3.8 Hz, 12 H, Me2SiH), 0.60 (m, 10 H, SiCH2), 
1.36 (m, 4 H,SiCH2CH2CH2Si), 1.72 (m, 2 H, ClCH2CH2), 3.48 (t, J = 6.9 Hz, 2 H, ClCH2), 3.82 (m, 2 H, 
SiH); 13C{1H}-NMR (CDCl3): δ -5.2 (MeSi), -4.4 (Me2SiH), 11.6 (ClCH2CH2CH2), 17.8, 18.8 and 18.9 
(SiCH2CH2CH2Si), 27.7 (ClCH2CH2), 48.1 (ClCH2). 
29Si-NMR (CDCl3): δ -14.1 (Me2SiH), 2.3 (MeSi). 
Anal. Calc. C14H35ClSi3 (323.14 g/mol): C, 52.04; H, 10.92; Obt.: C, 52.45; H, 10.60. 
ClG2(SiMeCl2)2 (7). HSiMeCl2 (5.1 mL, 49.46 mmol) was added to a cooled (0º C) teflon-valve 
ampoule containing a solution of ClG1A2 (2.506 g, 12.37 mmol) and Kardsted’s catalyst (3 % mol) in 
hexane (3 mL) and the solution was stirred for 4 h at 60º C. Afterward, volatiles were removed under 
vacuum, hexane was added (10 mL) and the solution was filtered through active carbon. Removal of 
volatiles under vacuum gave 7 as colorless liquid (5.299 g, 99 %). This product is moisture sensitive and 
has to be stored under inert atmosphere. 
1H-NMR (CDCl3): δ -0.01 (s, 6 H, SiMe), 0.05 (s, 3H, SiMe), 0.66 (m, 6 H, ClCH2CH2CH2SiCH2), 0.76 
(s, 6 H, MeSiCl2), 1.19 (m, 4 H, CH2SiMeCl2), 1.52 (m, 4 H, SiCH2CH2CH2Si), 1.74 (m, 2 H, ClCH2CH2), 
3.50 (t, J =7.0 Hz, 2 H, ClCH2); 
13C{1H}-NMR (CDCl3): δ -5.3 (SiMe), 5.4 (MeSiCl2), 11.2 
(ClCH2CH2CH2), 17.2 (SiCH2), 17.2 (SiCH2CH2), 25.8 (CH2SiCl2), 27.5 (ClCH2CH2), 47.9 (ClCH2).; 
29Si-
NMR (CDCl3): δ 2.3 (MeSi), 32.2 (MeSiCl2).  
ClG2A4 (8). BrMg(C3H5) (59.4 mL, 59.40 mmol) was slowly added to a cooled Et2O solution of 
ClG2(SiMeCl2)2 (5.299 g, 12.40 mmol). The reaction mixture was refluxed for 3 hours and afterwards 
stirred overnight at room temperature. Next, a water solution of NH4Cl was added (12%), the organic phase 
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was separated and the aqueous phase was extracted twice with Et2O. The organic phase was washed with 
brine, dried over MgSO4 and SiO2. The solution was filtered through active carbon and the volatiles were 
removed under vacuum, yielding 8 as colorless liquid (5.246 g, 94 %). 
1H-NMR (CDCl3):
 δ -0.07 (s, 3 H, MeSi), -0.03 (s, 6 H, MeSi(C3H5)2), 0.58 (m, 8 H, CH2Si), 1.32 (m, 4 
H, SiCH2CH2CH2Si), 1.52 (d, Jb = 8.2 Hz, 8 H, SiCH2CH), 1.72 (m, 2 H, ClCH2CH2), 3.47 (t, Jc = 6.9 Hz, 
2 H, ClCH2), 4.83 (m, 8 H, CH=CH2), 5.75 (m, 4 H, CH=CH2). 
13C{1H}-NMR (CDCl3): δ -5.8 
(MeSi(C3H5)2), -5.2 (MeSi), 11.5 (ClCH2CH2CH2), 17.9, 18.1 and 18.5 (SiCH2CH2CH2Si), 21.3 
(CH2CH=CH2), 27.7 (ClCH2CH2), 48.0 (ClCH2), 113.0 (CH=CH2), 134.8 (CH=CH2); 
29Si-NMR (CDCl3): 
2.0 (G1-SiMe), 0.1 (G2-SiMe). Anal. Calc. C25H49ClSi3 (469.37 g/mol): C, 63.97; H, 10.52; Exp.: C, 65.60; 
H, 10.10. 
ClG2(SiCl)4 (9). This product was synthesized following the synthetic procedure described for 5 from 8 
(1.058 g, 2.33 mmol) and HSiMe2Cl (2.0 mL, 18.38 mmol), obtainen 9 as colorless oil (1.861 g, 96 %). 
1H-NMR (CDCl3): δ -0.07 (s, 6 H, MeSi), 0.05 (s, 3 H, SiMe), 0.38 (s, 24 H, Me2SiCl), 0.57 (m, 18 H, 
SiCH2), 0.86 (m, 8 H, CH2SiCl), 1.28 (m, 4 H, SiCH2CH2CH2Si), 1.42 (m, 8 H, SiCH2CH2CH2Si), 1.80 
(m, 2 H, ClCH2CH2), 3.47 (t, J = 6.9 Hz, 2 H, ClCH2). 
13C{1H}-NMR (CDCl3): -5.0 (MeSi), 1.8 (Me2Si), 
11.6 (ClCH2CH2CH2), 17.7-18.7 (SiCH2CH2CH2Si), 23.5 (CH2SiCl), 27.8 (ClCH2CH2), 48.1 (ClCH2); 
29Si-NMR (CDCl3): 2.1 (MeSi), 31.1 (Me2SiCl). 
ClG2(SiH)4 (10). This product was obtained following the synthetic procedure described for 6 from 9 
(1.861 g, 2.24 mmol) and LiAlH4 (2.60 mL, 5.20 mmol), obtaining 10 as colorless oil (1.158 g, 75 %). 
1H-NMR (CDCl3): δ -0.09 and -0.06 (s, 9 H, MeSi), 0.04 (d, J = 3.9 Hz, 24 H, Me2SiH), 0.59 (m, 26 H, 
SiCH2), 1.36 (m, 6 H, SiCH2CH2CH2Si), 1.72 (m, 2 H, ClCH2CH2), 3.48 (t, J = 7.0 Hz, 2 H, ClCH2), 3.84 
(m, 4 H, SiH). 13C{1H}-NMR (CDCl3): δ -5.0 (MeSi), -4.4 (Me2SiH), 11.7 (ClCH2CH2CH2), 18.1-19.0 
(SiCH2CH2CH2Si), 27.8 (ClCH2CH2), 48.1 (ClCH2). 
29Si-NMR (CDCl3): δ -14.1 (Me2SiH), 1.1 (G2-SiMe), 
2.1 (G1-SiMe). Anal. Calc. C32H79ClSi7 (696.02 g/mol): C, 55.22; H, 11.44; Obt.: C, 56.45; H, 11.04. 
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ClG1(Si-NMe2)2 (11). An excess of allyl-dimethylamine (0.21 mL, 1.76 mmol) and two drops of 
Karsted´s catalyst were added to a solution of 6 (0.145 g, 0.44 mmol) in THF (2 mL). The reaction mixture 
was heated at 80 ºC in a sealed ampoule under inert atmosphere for one night and then evaporated to 
dryness to remove the solvent and residual allyl-dimethylamine. Afterwards, hexane (10 mL) was added 
and the solution was filtered through active carbon and dried under vacuum to give 11 as pale yellow oil 
(0.194 g, 88 %). 
1H-NMR (CDCl3): δ -0.06 (s, 12 H, SiMe2), 0.04 (s, 3 H, SiMe), 0.44 (t, Ja = 8.4 Hz, 4 H, 
SiCH2CH2CH2N), 0.57 (m, 10 H, SiCH2CH2CH2Si and ClCH2CH2CH2Si), 1.29 (m, 4 H, 
SiCH2CH2CH2Si), 1.42 (m, 4 H, SiCH2CH2CH2N), 1.72 (m, 2 H, ClCH2CH2), 2.19 (m, 16 H, CH2NMe2), 
3.47 (t, Jb = 6.9 Hz, 2 H, ClCH2). 
13C{1H}-NMR (CDCl3): δ -5.2 (SiMe), -3.4 (SiMe2), 11.6 
(ClCH2CH2CH2Si), 12.8 (SiCH2CH2CH2N), 18.3, 18.5 and 20.0 (SiCH2CH2CH2Si), 22.1 
(SiCH2CH2CH2NMe2), 27.7 (ClCH2CH2), 45.5 (-NMe2), 48.1 (ClCH2), 63.4 (CH2NMe2). MS: [M+H]
+ = 
493.4 uma (calcd. = 493.4 uma). Anal. Calc. C24H57ClN2Si3 (493.43 g/mol): C, 58.42; H, 11.64; N, 5.68; 
Exp.: C, 58.89; H, 11.57; N, 5.81.  
ClG2(Si-NMe2)4 (12). This product was synthesized following the synthetic procedure described for 11 
from ClG2(SiH)4 (0.512 g, 0.74 mmol) and C3H5NMe2 (0.70 mL, 5.91 mmol), giving 12 as yellowish oil 
(0.763 g, 99 %). 
1H-NMR (CDCl3): δ -0.07 (s, 24 H, SiMe2), 0.03 (s, 9 H, SiMe), 0.45 (m, 8 H, SiCH2CH2CH2N), 0.56 
(m, 26 H, SiCH2CH2CH2Si and ClCH2CH2CH2Si, overlapped), 1.30 (m, 8 H, SiCH2CH2CH2Si), 1.41 (m, 8 
H, SiCH2CH2CH2N), 1.73 (m, 2 H, ClCH2CH2), 2.18 (m, 32 H, -NMe2 and CH2NMe2), 3.46 (t, Jb = 6.8 Hz, 
2 H, ClCH2). 
13C{1H}-NMR (CDCl3): δ -5.1 and -5.0 (SiCH3), -3.3 (SiMe2), 11.6 (ClCH2CH2CH2Si), 12.9 
(SiCH2CH2CH2N), 18.4-20.1 (SiCH2CH2CH2Si), 22.1 (SiCH2CH2CH2NMe2), 27.8 (ClCH2CH2), 45.5 (-
NMe2), 48.1 (ClCH2), 63.4 (CH2NMe2). 
29Si-NMR (CDCl3):  2.1 (G1 SiMe), 0.9 (G2–SiMe), 1.9 (G2–
SiMe2). MS: [M+H]
+ = 1035.8 uma (calcd. = 1035.8 uma).Anal. Calc. C52H123ClN4Si7 (1036.61 g/mol): C, 
60.25; H, 11.96; N, 5.40; Exp.: C, 58.53; H, 11.10; N, 4.62.  
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ClG1(Si-NMe3I)2 (13). A mixture of 11 (0.220 g, 0.44 mmol) and MeI (0.11 mL, 1.76 mmol) in THF 
(50 mL) were stirred for 16 h. Afterwards, volatiles were removed under vacuum and the remaining solid 
was washed with Et2O (50 mL), obtaining 13 as a white solid (0.300 g, 87 %). 
1H-NMR (DMSO-d6):  -0.07 (s, 3 H, SiMe), 0.00 (s, 12 H, SiMe2), 0.38 and 0.56 (m, 14 H, SiCH2), 
1.31 (m, 4 H, SiCH2CH2CH2Si), 1.62 (m, 6 H, CH2CH2N
+ and ClCH2CH2), 3.05 (s, 18 H, -NMe3
+), 3.25 (t, 
Ja = 7.8 Hz, 4 H, CH2N
+), 2.58 (t, Jb = 6.5 Hz, ClCH2). 
13C{1H}-NMR (DMSO-d6):  -5.6 (SiMe), -3.9 
(SiMe2), 10.6 (SiCH2CH2CH2N
+), 16.4-17.4 (SiCH2CH2CH2Si), 18.6 (CH2CH2N
+), 26.7 (ClCH2CH2), 47.8 
(ClCH2), 51.6 (-NMe3
+), 67.4 (SiCH2CH2CH2NMe3
+). 29Si-NMR (DMSO-d6):  2.1 (SiMe), 2.4 (SiMe2). 
ESI: (776.21 g/mol) q=1 (649.31 [M-I]+). Anal. Calc. C26H63ClI2N2Si3 (777.31 g/mol): C, 40.17; H, 8.17; 
N, 3.60; Exp.: C, 40.78; H, 8.39; N, 3.93.  
ClG2(Si-NMe3I)4 (14). This product was synthesized following the synthetic procedure described for 
13 from 12 (0.638 g, 0.62 mmol) and MeI (0.16 mL, 2.59 mmol), which led to 14as white solid (0.805 g, 
81 %). 
1H-NMR (DMSO-d6):  -0.09 (s, 9 H, SiMe), -0.01 (s, 24 H, SiMe2), 0.37 and 0.57 (m, 34 H, SiCH2, 
overlapped), 1.30 (m, 12 H, SiCH2CH2CH2Si), 1.61 (m, 10 H, CH2CH2N
+ and ClCH2CH2), 3.03 (s, 36 H, -
NMe3
+), 3.23 (t, Ja = 8.3 Hz, 8 H, CH2N
+), 3.57 (t, Jb = 6.4 Hz, 2 H, ClCH2). 
13C{1H}-NMR (DMSO-d6):  
-5.3 (SiMe), -3.9 (SiMe2), 10.7 (SiCH2CH2CH2N
+), 16.4–17.7 (SiCH2CH2CH2Si), 18.8 (CH2CH2N
+), 26.7 
(ClCH2CH2), 47.8 (ClCH2), 51.6 (NMe3
+), 67.4 (SiCH2CH2CH2NMe3
+). 29Si-NMR (CDCl3):  2.2 (G1–Si), 
1.1 (G2–SiMe), 2.4 (G2–SiMe2). ESI: q=2 (674.35; [M-2I]
2+), q=3 (407.28; [M-3I]3+) and q=4 (273.7; [M-
4I]4+). Anal. Calc. C56H135ClI4N4Si7 (1604.37 g/mol): C, 41.92; H, 8.48; N, 3.49; Exp.: C, 42.22; H, 8.27; 
N, 3.46.  
(PenV)G1(Si-NMe3I)2 (15). To a solution of 13 (0.050 g, 0.06 mmol) in dry DMF, PenVK (0.027 g, 
0.07 mmol) was added in the presence of 18C6 (0.002 g, 0.01 mmol) and a catalytic amount of NaI. The 
mixture was heated at 80 ºC in a sealed ampoule under argon atmosphere for 2 nights after which volatiles 
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were removed. After washing the residues with water, dendron 15 was obtained as a very hygroscopic 
white solid (0.062 g, 89 %). 
1H-NMR (CDCl3):  0.00 (s, 12 H, SiMe2), 0.04 (s, 3 H, SiMe), 0.57 (m, 14 H, SiCH2), 1.29 (m, 4 H, 
SiCH2CH2CH2Si), 1.48 (s, 3 H, CMe2), 1.58 (s, 3 H, CMe2), 1.70 (m, 6 H, CH2CH2N
+ and OCH2CH2), 3.41 
(s, 18 H, -NMe3
+), 3.63 (m, 4 H, CH2N
+), 4.08 (t, Ja = 8.4 Hz, 2 H, (CO)OCH2), 4.43 (s, 1 H, CH(CMe2)), 
4.53 (s, 2 H, OCH2CO), 5.56 (d, Jb = 4.3 Hz, 1 H, CHS), 5.70 (m, 1 H, NHCH), 6.90 (d, Jc = 7.6 Hz, 2 H, 
CHAr), 7.01 (t, Jd = 7.4 Hz, 1 H, CHAr), 7.30 (m, 2 H, CHAr). 
13C{1H}-NMR (CDCl3):  -5.0 (SiCH3), -3.2 
(SiMe2), 9.9 (CH2Si), 11.4 (SiCH2CH2CH2N
+), 17.9, 18.0 and 18.3 (SiCH2CH2CH2Si), 19.8 (CH2CH2N
+), 
23.2 (OCH2CH2), 26.8 and 32.0 (SCMe2), 53.7 (-NMe3
+), 58.0 (NHCH), 64.7 (SCMe2), 67.1 (CH2N
+), 67.7 
(OCH2CO), 68.4 (COOCH2), 69.5 (CHS), 70.5 (CHCOO), 114.7 (CHAr), 122.4 (CHAr), 129.8 (CHAr), 
156.8 (COAr), 167.6, 167.8 and 173.0 (C=O). ESI: (1090.32 g/mol) q = 1 (963.42 [M-I]
+), q = 2 (418.26 
[M-2I]2+). Anal. Calc. C42H80I2N4O5SSi3 (1091.24 g/mol): C, 46.23; H, 7.39; N, 5.13; Exp.: C, 45.94; H, 
7.07; N, 4.43.  
(PenV)G2(Si-NMe3I)4 (16). This product was synthesized following the synthetic procedure described 
for 15 from 14 (0.120 g, 0.07 mmol), PenCO2K (0.030 g, 0.08 mmol) and 18C6 (0.002 g, 0.01 mmol) but 
heating at 100º C, obtaining 16 as a highly hygroscopic white solid (0.136 g, 95 %). In this case 
purification was performed using dyalysis with a membrane of MWCO of 500. 
1H-NMR (DMSO-d6):  -0.13 (s, 9 H, SiMe), 0.00 (s, 24 H, SiMe2), 0.41and 0.57 (m, 34 H, SiCH2), 
1.27 (m, 12 H, SiCH2CH2CH2Si), 1.61 (m, 16 H, CMe2, CH2CH2N
+ and OCH2CH2), 3.07 (s, 36 H, -
NMe3
+), 3.21 (m, 8 H, CH2N
+), 4.07 (m, 2 H, (CO)OCH2), 4.41 (s, 1 H, CH(CO)), 4.58 (s, 2 H, OCH2CO), 
5.57 (m, 1 H, CHS), 5.61 (m, 1 H, NHCH), 6.97 (m, 3 H, CHAr), 7.31 (m, 2 H, CHAr). 
13C{1H}-NMR 
(DMSO-d6):  -5.6 and -5.4 (SiMe), -3.9 (SiMe2), 8.9 (OCH2CH2CH2Si), 10.6 (SiCH2CH2CH2N+), 16.4-
17.7 (SiCH2CH2CH2Si), 18.7 (CH2CH2N
+), 22.1 (OCH2CH2 and SC(Me)2), 51.6 (-NMe3
+), 57.9 (NHCH), 
63.5 (SCMe2), 65.6 (OCH2CO), 66.9 (OCH2), 67.4 (CH2N
+), 69.4 (CHCOO), 113.9 (CHAr), 120.7 (CHAr), 
129.0 (CHAr), 157.0 (COAr), 167.2, 167.3, and 172.5 (C=O). 
29Si-NMR (DMSO-d6):  1.1 (G2–SiMe) 2.2 
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(G1–SiMe), 2.4 (G2–SiMe2). ESI: q=2 (831.4; [M-2I]
2+), q=3 (512.0; [M-3I]3+) and q=4 (352.2; [M-4I]4+). 
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S.3 Reaction schemes and NMR spectra.  
 
Scheme S1. Synthesis of dendron (PenV)G1V2 (1). i) DMF, 90 ºC, ether crown 18-C-6. 
 
Scheme S2. Synthesis of dendron ClG1(S-NMe3





Figure S1. 1H-NMR (DMSO-d6) spectra of compound ClG2(Si-NMe3
+)4 (14). 
 





Figure S3. MS spectrum of [(PenV)G2(Si-NMe3)4(I)4] (16) (a), observing the presence of the fragment [M-
2I]2+ (b). 
 





Figure S5. TOCSY (DMSO-d6) spectra of compound (PenV)G2(Si-NMe3
+)4 (16). 
 
Figure S6. 1H NMR and DOSY 2D spectra (D2O) of free PenV (red) and 
1H NMR and DOSY 2D 
spectra (D2O) of an equimolecular mixture of PenVK and dendron [ClG2(Si-NMe3)4]
4+ (14) (black). 
